DIABESITY INSTITUTE (EIN 454917504) - Form 990 Financial Analysis & Trantor Score

🔒

Financial Vulnerability Assessment (Tuckman-Chang)

4 risk indicators measuring financial stability and operational resilience

Sign in with your work email to view Tuckman-Chang indicators

Financial Trends

Organization Details

Formation Year

2012

Legal Domicile

Principal Officer

JANET FROHNMAYER

Phone

2066324575

Tax Period

2023-01-01 to 2023-12-31

DIABESITY INSTITUTE, founded in 2012, is a small nonprofit in the Medical Research sector that reported $255K in total revenue in fiscal year 2023. Revenue surged 54% from the prior year, signaling strong growth momentum. The organization ran a surplus of $50K, a strong 20% operating margin.

Mission

TO INCREASE ACCESS TO EFFECTIVE MEDICAL CARE FOR THOSE SUFFERING FROM DIABESITY BY ADVANCING THE SCIENCE OF METABOLISM.

🔒

Trantor Score

Financial Health Score (300–850) · Liquidity · Solvency · Sustainability · Efficiency

Sign in to view Trantor Score and financial metrics

Liquidity (40%) • Solvency (30%) • Sustainability (20%) • Efficiency (10%)

Financial Overview (2023)

Revenue Breakdown

Contributions & Grants $252,609

Program Service Revenue $0

Investment Income $0

Other Revenue $2,389

TOTAL REVENUE $254,998

Expense Breakdown

Grants Paid $0

Salaries & Benefits $0

Fundraising Expenses $0

Program Expenses $177,691

Other Expenses $205,178

TOTAL EXPENSES $205,178

Year-over-Year Comparison

	2023	2022	Change
Revenue	$254,998	$165,901	+0.5%
Expenses	$205,178	$183,029	+0.1%
Net Income	$49,820	$-17,128	-3.9%

Key Indicators

✗ Grants to Organizations ✗ Grants to Individuals ✗ Lobbying ✗ Political Activity ✗ Foreign Activities ✗ Donor Advised Fund ✓ Schedule B Required

🔒

Financial Health Indicators

Comprehensive financial analysis: Altman Z-Score, liquidity, solvency, sustainability, efficiency, and growth metrics

Financial Distress Indicator

Liquidity & Cash Position

Sign in to view all financial metrics

Altman Z-Score • Liquidity Ratios • Solvency Analysis • Growth Indicators • Efficiency Metrics

Governance

Voting Members

Independent Members

Employees

N/A

Volunteers

Governance Policies

✗ Conflict of Interest Policy

✗ Whistleblower Policy

✗ Document Retention Policy

Special Practices & Reported Activities

✗ Operated a School

✗ Operated a Hospital

✗ Provided First Class Travel

✗ Reported Conflict of Interest

✗ Reported Asset Diversion

✗ Excess Benefit Transaction

✗ Made Political Expenditures

✗ Engaged in Lobbying

✗ Operated Donor Advised Fund

✗ Maintained Art Collections

✗ Filed Form 720

Compensation of Officers, Directors & Key Employees

Total Officers

Total Directors

Key Employees

Highest Compensated

reported

Name	Title	Hours/Week	Role	Reportable Comp	Other Comp	Total
EMILY COOPER MD	EXECUTIVE DIRECTOR	10.00	Officer Director	$0	$0	$0
JANET FROHNMAYER	PRESIDENT	6.00	Officer Director	$0	$0	$0
CAROL WOLLENBERG	TREASURER	0.10	Officer Director	$0	$0	$0
ANDREA TAYLOR	DIRECTOR	5.00	Director	$0	$0	$0

Note: Compensation data is self-reported by the organization on their Form 990. "Reportable Comp" includes salary, bonuses, and other reportable compensation from the organization and related organizations. "Other Comp" includes benefits, deferred compensation, and non-taxable benefits.

Historical Data

Year	Revenue	Expenses	Assets	Net Income
2024	No data	No data	No data	No data
2023	$254,998	$205,178	$53,501	$49,820
2019	$229,677	$250,331	$78,049	$-20,654
2018	$397,195	$571,159	$121,239	$-173,964

DIABESITY INSTITUTE